ABSI

AbSci (ABSI)

AbSci Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ABSI

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	20:35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ABSI	AbSci Corporation
2024/05/14	20:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABSI	AbSci Corporation
2024/05/14	20:30	GlobeNewswire Inc.	Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results	NASDAQ:ABSI	AbSci Corporation
2024/04/16	21:00	GlobeNewswire Inc.	Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024	NASDAQ:ABSI	AbSci Corporation
2024/03/29	05:05	GlobeNewswire Inc.	Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:ABSI	AbSci Corporation
2024/03/21	20:30	GlobeNewswire Inc.	Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results	NASDAQ:ABSI	AbSci Corporation
2024/03/02	06:01	GlobeNewswire Inc.	Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares	NASDAQ:ABSI	AbSci Corporation
2024/02/29	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABSI	AbSci Corporation
2024/02/28	22:34	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ABSI	AbSci Corporation
2024/02/28	12:20	GlobeNewswire Inc.	Absci Announces Pricing of Public Offering of Common Stock	NASDAQ:ABSI	AbSci Corporation
2024/02/28	06:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABSI	AbSci Corporation
2024/02/28	06:40	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ABSI	AbSci Corporation
2024/02/28	06:01	GlobeNewswire Inc.	Absci Announces Proposed Public Offering of Common Stock	NASDAQ:ABSI	AbSci Corporation
2024/02/21	21:30	GlobeNewswire Inc.	Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI	NASDAQ:ABSI	AbSci Corporation
2024/02/20	22:00	GlobeNewswire Inc.	Absci to Participate in Upcoming Investor Conferences	NASDAQ:ABSI	AbSci Corporation
2024/02/14	08:16	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ABSI	AbSci Corporation
2024/02/06	09:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABSI	AbSci Corporation
2024/02/06	09:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABSI	AbSci Corporation
2024/02/06	09:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABSI	AbSci Corporation
2024/02/06	09:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABSI	AbSci Corporation
2024/01/10	21:30	GlobeNewswire Inc.	Absci Appoints Professor Sir Mene Pangalos to its Board of Directors	NASDAQ:ABSI	AbSci Corporation
2024/01/08	21:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABSI	AbSci Corporation
2024/01/08	21:00	GlobeNewswire Inc.	Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:ABSI	AbSci Corporation
2024/01/05	06:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABSI	AbSci Corporation
2024/01/05	06:57	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ABSI	AbSci Corporation
2024/01/03	22:00	GlobeNewswire Inc.	Absci to Participate in the 26th Annual Needham Growth Conference	NASDAQ:ABSI	AbSci Corporation
2023/12/28	22:00	GlobeNewswire Inc.	Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:ABSI	AbSci Corporation
2023/12/20	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABSI	AbSci Corporation
2023/12/20	21:30	GlobeNewswire Inc.	Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline	NASDAQ:ABSI	AbSci Corporation
2023/12/07	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABSI	AbSci Corporation